Salim Dhanji

Director Ejecutivo en ME THERAPEUTICS HOLDINGS INC. .

Fortuna: 20 M $ al 30/04/2024

44 años

Health Technology

Consumer Services

Perfil

Salim Zulifkar Dhanji is currently the Chief Executive Officer & Executive Director at ME Therapeutics Holdings, Inc. since 2023 and the President at Perceptive Property Development since 2013.
He previously worked as the Director-Preclinical Research at Qu Biologics, Inc. from 2009 to 2014.
Dr. Dhanji received his undergraduate degree in 2001 and his doctorate in 2006 from the University of British Columbia.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
ME THERAPEUTICS HOLDINGS, INC. 17.72%	05/02/2024	4 175 143 ( 17.72% )	20 M $	30/04/2024

Cargos activos de Salim Dhanji

Empresas	Cargo	Inicio
ME THERAPEUTICS HOLDINGS INC.	Director Ejecutivo	09/03/2023

Todos los cargos activos de Salim Dhanji

Antiguos cargos conocidos de Salim Dhanji.

Empresas	Cargo	Fin
Qu Biologics, Inc. Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.	Corporate Officer/Principal	01/01/2014

Ver el detalle de la experiencia de Salim Dhanji.

Formación de Salim Dhanji.

University of British Columbia

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Salim Dhanji.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ME THERAPEUTICS HOLDINGS INC.	Health Technology

Empresas privadas	1
Qu Biologics, Inc. Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.	Health Technology